Skip to content
HomeAccess to therapy for pancreatic cancer: Pancreatic Cancer Europe and Anticancer Fund to host Multistakeholder Meeting

Access to therapy for pancreatic cancer: Pancreatic Cancer Europe and Anticancer Fund to host Multistakeholder Meeting

Together with the Anticancer Fund and supported by the European Pancreatic Club, we are excited to announce the “Getting Our Act Together – Multistakeholder Meeting on Access to Therapy for Pancreatic Cancer,” scheduled for June 25, 2024. This event, held in Santiago de Compostela, Spain, will bring together leading professionals from oncology, surgery, gastroenterology, pharmacology, patient advocacy, and policy-making.

Structured around several sessions, the program will cover topics such as best practices in standard care treatments, the role of clinical trials, holistic treatment approaches, and innovative strategies in patient care. Each session will be followed by roundtable discussions to define specific actions and identify leads for future initiatives.

PROGRAMME

Opening

  • Enrique Domínguez Muñoz – European Pancreatic Club – Austria
  • Alfredo Carrato – Pancreatic Cancer Europe – Belgium
  • Ilse Rooman – Anticancer Fund – Belgium

Session 1. Patient priorities in treatment

  • André Mihaljevic – Universitätsklinikum und Medizinische Fakultät Tübingen – Germany

Session 2. Best practices in identifying treatments 

  • Paolo Arcidiacono – I.R.C.C.S. Ospedale San Raffaele – Italy
  • Roeland Frederik de Wilde – Erasmus University Medical Center, Netherlands

Session 3. Best practices in SOC treatments 

  • Max Heckler – Klinik für Allgemein-, Viszeral- und Transplantationschirurgie Universitätsklinikum Heidelberg – Germany
  • Aistė Kielaitė-Gulla – Vilnius University · Clinic of Gastroenterology, Nephrourology and Surgery – Lithuania
  • Talia Golan – Sheba Medical Centre – Israel

Session 4. Clinical trials

  • Liese Vandeborne – Anticancer Fund – Belgium
  • Nicola Murphy – PCUK – United Kingdom
  • David Chang – University of Glasgow, United Kingdom

Session 5. Holistic treatments

  • Joseph Williams – British Oncology Pharmacy Association – United Kingdom
  • Oonagh Griffin –  St Vincent’s University Hospital Dublin & University College Dublin
  • Paula Ravasco – Catolica medical School – Portugal
  • Nicola Murphy – PCUK – United Kingdom

Session 6. Call to actions

  • Thomas Seufferlein – Ulm University – Germany
  • Alfredo Carrato – Pancreatic Cancer Europe – Spain
  • Gabriele Capurso – European Pancreatic Club – Italy
  • Patrick Michl – United European Gastroenterology – Germany
  • Ana Martins – Digestive Cancers Europe – Belgium
  • Francisco Lozano – Cancer Patients Europe – Belgium
  • Christelle Bouchart – Institut Jules Bordet- HUB – Belgium
  • Violeta Vladimirova Stoyanova-Beninska – Committee for Orphan Medicinal Products at European Medicines Agency – Netherlands
  • Ansgar Hebborn – The European Federation of Pharmaceutical Industries and Associations (EFPIA) – Belgium

PCE and the Anticancer Fund are committed to advancing research and improving access to care for pancreatic cancer patients across Europe. This meeting will be a significant step towards bridging gaps in care and enhancing treatment protocols through collaborative efforts.

While the event is invitation-only, outcomes will be shared post-event. Subscribe to our newsletter for exclusive updates and comprehensive reports.